about
Antiangiogenic gene therapy of cancer: recent developmentsInterleukin 12: still a promising candidate for tumor immunotherapy?In-situ tumor vaccination: Bringing the fight to the tumorType-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines.Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein DPhase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanomaAbrogation of TNFα production during cancer immunotherapy is crucial for suppressing side effects due to the systemic expression of IL-12.Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.Tissue-specific promoters for cancer gene therapy.Antisense therapy for restenosis following percutaneous coronary intervention.Electroporation for targeted gene transfer.Immunotherapy and immunoescape in colorectal cancer.Gene therapy: regulations, ethics and its practicalities in liver disease.Immunotherapy for liver tumors: present status and future prospects.Coexpression of IL-18 strongly attenuates IL-12-induced systemic toxicity through a rapid induction of IL-10 without affecting its antitumor capacity.New approaches to the development of adenoviral dendritic cell vaccines in melanoma.Efficient expression of bioactive murine IL12 as a self-processing P2A polypeptide driven by inflammation-regulated promoters in tumor cell lines.Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo.Bleomycin/interleukin-12 electrochemogenetherapy for treating naturally occurring spontaneous neoplasms in dogs.Enhanced anti-tumor effect of a gene gun-delivered DNA vaccine encoding the human papillomavirus type 16 oncoproteins genetically fused to the herpes simplex virus glycoprotein D.Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytesReversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12.Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity.Feasibility of Applying Helper-Dependent Adenoviral Vectors for Cancer Immunotherapy.
P2860
Q24803786-63842ECC-4BB5-454D-B81F-A3980B9C0778Q26861559-5272879B-FB4F-4E1E-BB3C-28BB351AC07BQ26991976-3B376A5E-CDBF-430D-9657-9340B70A970AQ34009362-6E2EC333-0267-44B6-BFAA-D100F320CDE0Q34189966-C7FC0430-BDB6-4516-A1B6-ABFD7F238896Q34887442-925BB752-01E4-4AC4-8023-434DB442BC1DQ35108695-0517ED3C-7352-44A9-969F-17BEF6DE66A1Q35140904-1EB64227-D1CB-4BF8-B654-C16268B4FB32Q35779378-9A5188C9-5D90-46A0-9D83-0D4932E29C5BQ36040825-29C380FB-807A-4C9B-B6EC-8E979EE949E3Q36316716-BFBD9112-AA03-4083-9085-8EAAD7F43DF3Q36996316-C9151B35-7B35-4DEF-9C23-DF31408FC53CQ37139713-7CE22883-3965-435C-96BF-9BC2CDBE34E0Q37144014-98B6921C-FC56-44A1-A00B-BBAE1680865FQ37462813-AE88E465-A94B-4703-A8EC-0E94A787C30AQ37820489-46906926-AAAD-4B0F-8CD8-A4CCFA358A20Q38829316-108F8578-8756-4442-9088-66AC5A64E788Q39101230-83290BA9-F0BE-4CB2-BFEF-6C45F54E07ECQ39711573-D3DF3366-B0C5-45B2-8D52-3BE57EBA6EACQ39766780-71423080-1F7E-4675-80A5-0941D8C46BB4Q39874482-08DB6E58-ABD8-4C94-9A39-DC7164BB8F86Q41132577-17404B54-FED7-4260-9514-BBD37ADCA1E3Q43247295-B0E6F619-F8D4-4C0D-B355-F98C238DDFCEQ51847569-FC5E07CE-31FA-426E-A37C-4C1DC317BE8D
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Gene therapy of cancer with interleukin-12.
@en
Gene therapy of cancer with interleukin-12.
@nl
type
label
Gene therapy of cancer with interleukin-12.
@en
Gene therapy of cancer with interleukin-12.
@nl
prefLabel
Gene therapy of cancer with interleukin-12.
@en
Gene therapy of cancer with interleukin-12.
@nl
P356
P1476
Gene therapy of cancer with interleukin-12.
@en
P2093
Guillermo Mazzolini
Ignacio Melero
P304
P356
10.2174/1381612033454261
P50
P577
2003-01-01T00:00:00Z